Conclusion
MIH
MIH offers support for discharged patients to alleviate MRPs. More than 50% of the MRPs found in this study resulted in pharmacy interventions assessed to have a high- or moderate clinical significance. Although patients expressed a high satisfaction with the MIH, the access to the MIH did not significantly increase patients’ feeling of safety in relation to medicines use. This study emphasizes that patients value the service and the information provided by the MIH, and that the service might positively affect a safe medication after discharge. Changes in the medical treatment after discharge is challenging and patients should be provided with sufficient pharmaceutical support and information to overcome these struggles, ultimately ensuring a patient safe medication.